Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.04 is 82% above its 5-year average of -0.22, near the high end of its 5-year range (-0.37–-0.04).
58.33% above its 12-month average of -0.10.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.01.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:41:00.999Z. Historical observations retain their original dates. Historical series through 2006-05-02.
EARNINGS PER SHARE (EPS)
-0.04
EARNINGS PER SHARE (EPS) AVG TTM
-0.10
EARNINGS PER SHARE (EPS) AVG 3Y
-0.16
EARNINGS PER SHARE (EPS) AVG 5Y
-0.22
EARNINGS PER SHARE (EPS) AVG 10Y
-0.37
EARNINGS PER SHARE (EPS) AVG 15Y
-0.39
EARNINGS PER SHARE (EPS) AVG 20Y
-0.42
CURRENT VS TTM AVG
+58.33%
CURRENT VS 3Y AVG
+75.08%
CURRENT VS 5Y AVG
+81.98%
CURRENT VS 10Y AVG
+89.11%
CURRENT VS 15Y AVG
+89.78%
CURRENT VS 20Y AVG
+90.54%
Cerus Corporation
Market Cap
$468.55M
Earnings Per Share (EPS)
-0.04
TTM Avg
-0.10
3Y Avg
-0.16
5Y Avg
-0.22
Market Cap
$470.68M
Earnings Per Share (EPS)
0.16
TTM Avg
-2.02
3Y Avg
-3.99
5Y Avg
-3.80
Market Cap
$469.66M
Earnings Per Share (EPS)
-0.31
TTM Avg
-0.44
3Y Avg
-0.93
5Y Avg
-0.65
Market Cap
$474.97M
Earnings Per Share (EPS)
-1.73
TTM Avg
-1.90
3Y Avg
-1.16
5Y Avg
-1.16
Market Cap
$465.75M
Earnings Per Share (EPS)
-0.56
TTM Avg
-0.89
3Y Avg
-1.18
5Y Avg
-1.13
Market Cap
$474.32M
Earnings Per Share (EPS)
-1.99
TTM Avg
-0.88
3Y Avg
-1.91
5Y Avg
-1.95
Market Cap
$484.69M
Earnings Per Share (EPS)
-0.52
TTM Avg
-0.81
3Y Avg
-1.01
5Y Avg
-1.63
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cerus Corporation (CERS) | $468.55M | -0.04 | -0.10 | -0.16 | -0.22 |
| Arvinas, Inc. (ARVN)vs › | $470.68M | 0.16 | -2.02 | -3.99 | -3.80 |
| Kamada Ltd. (KMDA)vs › | $469.86M | 0.38 | 0.32 | 0.19 | 0.19 |
| Alpha Teknova, Inc. (TKNO)vs › | $469.66M | -0.31 | -0.44 | -0.93 | -0.65 |
| Contineum Therapeutics, Inc. (CTNM)vs › | $474.97M | -1.73 | -1.90 | -1.16 | -1.16 |
| Sight Sciences, Inc. (SGHT)vs › | $465.75M | -0.56 | -0.89 | -1.18 | -1.13 |
| Bright Minds Biosciences Inc. (DRUG)vs › | $474.32M | -1.99 | -0.88 | -1.91 | -1.95 |
| NRC Health (NRC)vs › | $454.45M | 0.25 | 0.79 | 1.03 | 1.18 |
| Evolus, Inc. (EOLS)vs › | $484.69M | -0.52 | -0.81 | -1.01 | -1.63 |
| Puma Biotechnology, Inc. (PBYI)vs › | $485.07M | 0.52 | 0.62 | 0.43 | -0.09 |
Trailing EPS (TTM)
$-0.04
Forward EPS (Est.)
$-0.04
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.08 |
| 2024-12-31 | -0.11 |
| 2023-12-31 | -0.21 |
| 2022-12-31 | -0.24 |
| 2021-12-31 | -0.32 |
| 2020-12-31 | -0.37 |
| 2019-12-31 | -0.51 |
| 2018-12-31 | -0.44 |
| 2017-12-31 | -0.56 |
| 2016-12-31 | -0.62 |
| 2015-12-31 | -0.58 |
| 2014-12-31 | -0.52 |
| 2013-12-31 | -0.64 |
| 2012-12-31 | -0.29 |
| 2011-12-31 | -0.35 |
| 2010-12-31 | -0.42 |
| 2009-12-31 | -0.69 |
| 2008-12-31 | -0.90 |
| 2007-12-31 | -1.42 |
| 2006-12-31 | -0.18 |
| 2005-12-31 | 0.58 |
| 2004-12-31 | -1.41 |
| 2003-12-31 | -3.01 |
| 2002-12-31 | -3.61 |
| 2001-12-31 | -3.27 |
| 2000-12-31 | -2.75 |
| 1999-12-31 | -2.04 |
| 1998-12-31 | -3.17 |
| 1997-12-31 | -1.76 |
